CN106265827A - A kind of processing method of Lepidinm meyenii Walp tablet - Google Patents
A kind of processing method of Lepidinm meyenii Walp tablet Download PDFInfo
- Publication number
- CN106265827A CN106265827A CN201610655479.1A CN201610655479A CN106265827A CN 106265827 A CN106265827 A CN 106265827A CN 201610655479 A CN201610655479 A CN 201610655479A CN 106265827 A CN106265827 A CN 106265827A
- Authority
- CN
- China
- Prior art keywords
- meyenii walp
- lepidinm meyenii
- spirulina
- powder
- tablet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/748—Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/17—Preparation or pretreatment of starting material involving drying, e.g. sun-drying or wilting
Abstract
The open a kind of Lepidinm meyenii Walp tablet processing procedures of the present invention, by dry Lepidinm meyenii Walp raw material pulverizing to Lepidinm meyenii Walp microparticle and Lepidinm meyenii Walp wall cell disruption powder；Again Lepidinm meyenii Walp microparticle and Lepidinm meyenii Walp wall cell disruption powder are mixed in proportion, obtain Lepidinm meyenii Walp micropowder；By Spirulina powder crushed after being dried to spirulina microparticle and breaking wall of spirullina princeps powder；Then spirulina microparticle and breaking wall of spirullina princeps powder are mixed in proportion, obtain spirulina micropowder；Carry out Conventional compression after Lepidinm meyenii Walp micropowder, spirulina micropowder and glycerol being mixed in proportion, i.e. obtain Lepidinm meyenii Walp tablet.Gained Lepidinm meyenii Walp tablet complete appearance is bright and clean, and hardness reaches requirement, and disintegration, dissolution and tablet weight variation all meet the requirements.Not only there is the such high effect material of astaxanthin, and the proteinaceous nutrient composition being prone to digestion and absorbing can be provided quickly, the nutrient such as dietary fiber, mineral, trace element.
Description
Technical field
The present invention relates to a kind of Lepidinm meyenii Walp tablet processing procedures.
Background technology
Lepidinm meyenii Walp comes from the Andean a kind of crucifer of South America, suitably at High aititude, low latitudes, height round the clock
Growing in the temperature difference, subacidity sandy loam, sun-drenched soil, being introduced into the area such as Yunnan Province of China, Xinjiang has the cultivation of larger area
Training, 2015, only at Lijiang, yunnan Lepidinm meyenii Walp industrial base area just more than 140,000 mu.Lepidinm meyenii Walp is that a kind of pure natural medicine food dual-purpose is former
Material, it is nutritious, has the reputation of " South America Radix Ginseng ", has the effect improving immunity, strengthens prostatic function.Maca reactive
Composition be macamide (macamides) and Lepidinm meyenii Walp alkene (macaenes), balanced human's hormone secretion is had by both materials
Remarkable effect, the natural hormone electromotor so Lepidinm meyenii Walp is otherwise known as, eat used people have full of physical strength, spiritual vigorous will not
Tired sensation.From the point of view of feeding habits, Maca reactive is the most positive, and its active component is easy the most in the presence of oxygen, by soon
Speed volatilization and oxidation, occur that effectiveness reduces and even inactivate.Therefore, Lepidinm meyenii Walp is prepared as the product form of tabletting more, such as Publication No.
" CN104920762A ", the application for a patent for invention of entitled " a kind of Rhizoma Polygonati Lepidinm meyenii Walp pressed candy and preparation method thereof " and Publication No.
" CN104687048A ", the application for a patent for invention of entitled " a kind of Lepidinm meyenii Walp tabletting and preparation method thereof ", due to the Lepidinm meyenii Walp pulverized
Granule has certain shape and size, needs to add starch, use the filleies such as magnesium stearate, to ensure that tabletting remains certain
Profile, and can timely disintegrate in water.In sheeted product, having certain space between granule, oxygenolysis will be broken
The specific effect of bad product.Therefore, there are the form using capsule product, such as Publication No. " CN104873647A ", entitled " one
Kind of pueraria root powder capsule and preparation method thereof " application for a patent for invention, the capsule disclosing Lepidinm meyenii Walp and the composition such as Radix Ginseng, Radix Notoginseng produces
Product.
Spirulina contains rich in protein, vitamin, unsaturated fatty acid, various trace element and other nutrient
Matter, be so far the abundantest for the main animals and plants Middle nutrition composition found, equalize most, be best suitable for nutriment that human body needs it
One.Therefore, spirulina is recognized is the whole world preferably food.The spirulina of spontaneous growth is found in Lijiang, yunnan Cheng Hai lake
After, area, Cheng Hai lake just becomes spirulina production base maximum in the world.At present, spirulina breeding enters scale, intensive
Change production phase, annual nearly 4 kilotons of dry product produced.At present, study and one of the focus that produces is by spirulina cold drying
Rear direct compression, is used by most adaptation populations, such as Publication No. " CN102406178A ", entitled " a kind of interpolation
The spirulina tablet of glycerol and processing method thereof " application for a patent for invention, disclose the Spirulina powder of 60～120 mesh and glycerol by
After mass percent 100:1～3 mix homogeneously, it is pressed into tablet, adds glycerol and reduce the water activity of goods, extend Spirulina powder
Storage life.
Tabletting as health product and a kind of form processing of food, safety and sanitation, instant, nutrition and have special efficacy
The effective ingredient such as the material of property are not easy to be destroyed, long shelf-life.In view of the macamide in Lepidinm meyenii Walp and Lepidinm meyenii Walp alkene are fat-soluble
Material, there is no the product research report being similar to prevent quickly volatilize at present.
Summary of the invention
The technical problem to be solved is that spirulina Lepidinm meyenii Walp processing tablet has good mouldability, reduces Lepidinm meyenii Walp
Amide and the quick volatilization of Lepidinm meyenii Walp alkene, ensure that again its functional component is fully absorbed, improve the shelf-life, give full play to spiral
The advantage of both algae Lepidinm meyenii Walp.
The present invention solves the technical scheme that above-mentioned technical problem used: a kind of Lepidinm meyenii Walp tablet processing procedures, through under
Arrange each step:
(1) by dry Lepidinm meyenii Walp raw material pulverizing to the Lepidinm meyenii Walp microparticle that granularity is 150 mesh and agate that granularity is 1000～3000 mesh
Coffee wall cell disruption powder；Again by Lepidinm meyenii Walp microparticle and Lepidinm meyenii Walp wall cell disruption powder be in mass ratio 3～5:5～7 mixing, obtain Lepidinm meyenii Walp micropowder；
(2) being dried by Spirulina powder to moisture content is 3～4%, then is crushed to spirulina microparticle and grain that granularity is 150 mesh
Degree is the breaking wall of spirullina princeps powder of 1000～3000 mesh；Then by spirulina microparticle and breaking wall of spirullina princeps powder be in mass ratio 3～
5:5～7 mixing, obtains spirulina micropowder；
(3) get the raw materials ready by the component of following mass parts, and be mixed into mixture:
Lepidinm meyenii Walp micropowder is 50～60 parts, spirulina micropowder 35～45 parts, glycerol 4～6 parts；
(4) mixture of step (3) is carried out Conventional compression, i.e. obtain Lepidinm meyenii Walp tablet.
The dry Lepidinm meyenii Walp raw material of described step a is to be cleaned by the tuber of fresh Lepidinm meyenii Walp, and natural air drying is cut into thickness and is after 2 days
The lamellar of 0.2～0.5 centimetre, then be dried in being placed at 50 DEG C to moisture content be 5～9%.
Gained Lepidinm meyenii Walp tablet complete appearance is bright and clean, and hardness reaches requirement, and disintegration, dissolution and tablet weight variation all meet
Requirement.
Compared with prior art, it is an advantage of the current invention that by by after dry Lepidinm meyenii Walp raw material pulverizing, entering with Spirulina powder
The rational proportioning of row, using glycerol as protective agent, tabletting, it is provided that a kind of trophic structure with overall balance, class height,
Seal-packed Lepidinm meyenii Walp, spirulina sheeted product, it not only has the such high effect material of astaxanthin, and can be quickly
The proteinaceous nutrient composition being prone to digestion and absorbing, the nutrient such as dietary fiber, mineral, trace element are provided.
The stability of the indexs such as 1, production technology is the most easy, health is high, and the shelf-life is up to 18 months；
2, by pulverizing and gradation, making tabletting food individual uniformly, the glossiness of this product is good, and Color tunable is stable；
3, good mouldability, reduces the quick volatilization of macamide and Lepidinm meyenii Walp alkene, ensure that again its functional component is by fully
Absorb；
4, improve the shelf-life, give full play to the advantage of both spirulina Lepidinm meyenii Walp.
The present invention by pulverizing and gradation, can adjust pueraria root powder and ultramicro powder for different adaptation populations
Change the ratio of Lepidinm meyenii Walp, and the ratio of Lepidinm meyenii Walp, spirulina；The sheeted product obtained has excellent at mouldability, outward appearance, disintegration
Gesture, it is possible to take corresponding countermeasure, it is thus achieved that effect targetedly.
Detailed description of the invention
Below in conjunction with embodiment, the present invention is described in further detail.
Embodiment 1
(1) being cleaned by the tuber of fresh Lepidinm meyenii Walp, natural air drying is cut into the lamellar that thickness is 0.3 centimetre after 2 days, then is placed at 50 DEG C
Be dried to the dry Lepidinm meyenii Walp raw material that moisture content is 6%, be crushed to Lepidinm meyenii Walp microparticle that granularity is 150 mesh and granularity be 1000～
The Lepidinm meyenii Walp wall cell disruption powder of 3000 mesh；Again Lepidinm meyenii Walp microparticle and Lepidinm meyenii Walp wall cell disruption powder are mixed for 4:6 in mass ratio, obtain Lepidinm meyenii Walp micropowder；
(2) being dried by Spirulina powder to moisture content is 3%, then is crushed to spirulina microparticle that granularity is 150 mesh and granularity is
The breaking wall of spirullina princeps powder of 1000～3000 mesh；Then spirulina microparticle and breaking wall of spirullina princeps powder are mixed for 5:5 in mass ratio,
Obtain spirulina micropowder；
(3) get the raw materials ready by the component of following mass parts, and be mixed into mixture:
Lepidinm meyenii Walp micropowder is 60 parts, spirulina micropowder 35 parts, glycerol 5 parts；
(4) mixture of step (3) is carried out Conventional compression, i.e. obtain Lepidinm meyenii Walp tablet.
Tablet is bottled, after standing 12～24 hours, carries out evaluation test.Disintegration, dissolution and tablet weight variation all accord with
Close requirement, be shown in Table 1.
The objective relative standard of table 1 tablet Forming Quality
Embodiment 2
(1) being cleaned by the tuber of fresh Lepidinm meyenii Walp, natural air drying is cut into the lamellar that thickness is 0.2 centimetre after 2 days, then is placed at 50 DEG C
Be dried to the dry Lepidinm meyenii Walp raw material that moisture content is 5%, be crushed to Lepidinm meyenii Walp microparticle that granularity is 150 mesh and granularity be 1000～
The Lepidinm meyenii Walp wall cell disruption powder of 3000 mesh；Again Lepidinm meyenii Walp microparticle and Lepidinm meyenii Walp wall cell disruption powder are mixed for 3:7 in mass ratio, obtain Lepidinm meyenii Walp micropowder；
(2) being dried by Spirulina powder to moisture content is 3%, then is crushed to spirulina microparticle that granularity is 150 mesh and granularity is
The breaking wall of spirullina princeps powder of 1000～3000 mesh；Then spirulina microparticle and breaking wall of spirullina princeps powder are mixed for 3:7 in mass ratio,
Obtain spirulina micropowder；
(3) get the raw materials ready by the component of following mass parts, and be mixed into mixture:
Lepidinm meyenii Walp micropowder is 50 parts, spirulina micropowder 44 parts, glycerol 6 parts；
(4) mixture of step (3) is carried out Conventional compression, i.e. obtain Lepidinm meyenii Walp tablet.
Tablet is bottled, after standing 12～24 hours, carries out evaluation test.Disintegration, dissolution and tablet weight variation all accord with
Close requirement, be shown in Table 2.
The objective relative standard of table 2 tablet Forming Quality
Embodiment 3
(1) being cleaned by the tuber of fresh Lepidinm meyenii Walp, natural air drying is cut into the lamellar that thickness is 0.5 centimetre after 2 days, then is placed at 50 DEG C
Be dried to the dry Lepidinm meyenii Walp raw material that moisture content is 9%, be crushed to Lepidinm meyenii Walp microparticle that granularity is 150 mesh and granularity be 1000～
The Lepidinm meyenii Walp wall cell disruption powder of 3000 mesh；Again Lepidinm meyenii Walp microparticle and Lepidinm meyenii Walp wall cell disruption powder are mixed for 5:5 in mass ratio, obtain Lepidinm meyenii Walp micropowder；
(2) being dried by Spirulina powder to moisture content is 4%, then is crushed to spirulina microparticle that granularity is 150 mesh and granularity is
The breaking wall of spirullina princeps powder of 1000～3000 mesh；Then spirulina microparticle and breaking wall of spirullina princeps powder are mixed for 4:6 in mass ratio,
Obtain spirulina micropowder；
(3) get the raw materials ready by the component of following mass parts, and be mixed into mixture:
Lepidinm meyenii Walp micropowder is 55 parts, spirulina micropowder 45 parts, glycerol 4 parts；
(4) mixture of step (3) is carried out Conventional compression, i.e. obtain Lepidinm meyenii Walp tablet.
Tablet is bottled, after standing 12～24 hours, carries out evaluation test.Disintegration, dissolution and tablet weight variation all accord with
Close requirement, be shown in Table 3.
The objective relative standard of table 3 tablet Forming Quality
Contrast experiment:
Raw material prepares:
Lepidinm meyenii Walp fine powder: being cut into slices (0.2～0.5cm) by fresh Lepidinm meyenii Walp, 50 DEG C are dried under vacuum to water content is 3%, is dried Lepidinm meyenii Walp raw material
By pulverizing, form microparticle Lepidinm meyenii Walp (granule size is 80 mesh, only 8% sporoderm-broken rate).
Spirulina micropowder: with the spirulina micropowder of embodiment 1.
Comparative example 1: tabletting after Lepidinm meyenii Walp fine powder, spirulina micropowder and glycerol are mixed in the ratio of embodiment 1.
Comparative example 2: Lepidinm meyenii Walp fine powder, spirulina micropowder and glycerol are mixed in following ratio: Lepidinm meyenii Walp fine powder is 20 parts, spiral
Algae micropowder 75 parts, glycerol 5 parts, then tabletting.
Use direct powder compression, after mandatory filling, with 20 tons of punch die direct compressions.Tabletting terminates, by sheet
Agent is bottled, and stands 12～24 hours, is evaluated testing, is shown in Table 4:
The different preparation method of table 4 obtains the objective relative standard of tablet Forming Quality of Maca tablet
As shown in Table 4, use micronizing to obtain Lepidinm meyenii Walp micropowder, wherein contain 40% microparticle Lepidinm meyenii Walp and 60% ultramicro powder, agate
Coffee breaking cellular wall is complete, the beneficially dissolution of active component.In tablet formulation, Lepidinm meyenii Walp micropowder addition is 60 parts, direct powder compression
The tablet easy-formation, the tablet that obtain are the brightest and the cleanest, uniform color, disintegration moderate without fiber crops speckle, tablet hardness, dissolution reason
Think that (disintegration, dissolution ideal show that Lepidinm meyenii Walp tablet quality meets Chinese Pharmacopoeia regulation disintegration of tablet time limit and dissolution
Require).In contrast, using routine to pulverize and obtain Lepidinm meyenii Walp fine powder, granularity is 80 mesh, only 8% sporoderm-broken rate, is unfavorable for activity
The dissolution of composition.In tablet formulation, Lepidinm meyenii Walp fine powder is 60 parts, difficult molding in tableting processes, the phenomenon such as loose pieces, sliver occurs, no
It is beneficial to the packaging of tablet, transports and store.The disintegrate causing tablet because tablet hardness is the least, frangible is fast, dissolution is high and unfavorable
Packaging and storage in tablet；Only it is reduced Lepidinm meyenii Walp micropowder when being only 20 parts, easy-formation in tableting processes；But a small amount of tablet is still
There is loose pieces phenomenon.Tablet surface color and luster is uneven, pit occurs.More than testing explanation, Lepidinm meyenii Walp, after micronizing, obtains powder
End granule size is 1000～3000 mesh, after slightly solubility material micronizing in Lepidinm meyenii Walp, it is to avoid loose pieces, sliver, surface pit
Generation etc. phenomenon；Meanwhile, in tablet, the quality of Lepidinm meyenii Walp is up to 60%, can reduce tablets amount, increases complying with of consumer
Property.
Claims (2)
1. a Lepidinm meyenii Walp tablet processing procedures, it is characterised in that through following each step:
(1) by dry Lepidinm meyenii Walp raw material pulverizing to the Lepidinm meyenii Walp microparticle that granularity is 150 mesh and agate that granularity is 1000～3000 mesh
Coffee wall cell disruption powder；Again by Lepidinm meyenii Walp microparticle and Lepidinm meyenii Walp wall cell disruption powder be in mass ratio 3～5:5～7 mixing, obtain Lepidinm meyenii Walp micropowder；
(2) being dried by Spirulina powder to moisture content is 3～4%, then is crushed to spirulina microparticle and grain that granularity is 150 mesh
Degree is the breaking wall of spirullina princeps powder of 1000～3000 mesh；Then by spirulina microparticle and breaking wall of spirullina princeps powder be in mass ratio 3～
5:5～7 mixing, obtains spirulina micropowder；
(3) get the raw materials ready by the component of following mass parts, and be mixed into mixture:
Lepidinm meyenii Walp micropowder is 50～60 parts, spirulina micropowder 35～45 parts, glycerol 4～6 parts；
(4) mixture of step (3) is carried out Conventional compression, i.e. obtain Lepidinm meyenii Walp tablet.
Lepidinm meyenii Walp tablet processing procedures the most according to claim 1, it is characterised in that: the dry Lepidinm meyenii Walp raw material of described step a
Being to be cleaned by the tuber of fresh Lepidinm meyenii Walp, natural air drying is cut into the lamellar that thickness is 0.2～0.5 centimetre after 2 days, then is placed at 50 DEG C
In be dried to moisture content be 5～9%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610655479.1A CN106265827A (en) | 2016-08-11 | 2016-08-11 | A kind of processing method of Lepidinm meyenii Walp tablet |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610655479.1A CN106265827A (en) | 2016-08-11 | 2016-08-11 | A kind of processing method of Lepidinm meyenii Walp tablet |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106265827A true CN106265827A (en) | 2017-01-04 |
Family
ID=57668456
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610655479.1A Pending CN106265827A (en) | 2016-08-11 | 2016-08-11 | A kind of processing method of Lepidinm meyenii Walp tablet |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106265827A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1803025A (en) * | 2006-01-13 | 2006-07-19 | 宁波大学 | Laver product and its making process |
| CN102406178A (en) * | 2011-10-12 | 2012-04-11 | 丽江程海保尔生物开发有限公司 | Spirulina tablet added with glycerol and processing method thereof |
| CN104095897A (en) * | 2014-06-24 | 2014-10-15 | 伏思思 | Maca dunaliella salina compound preparation |
| CN104738618A (en) * | 2015-02-15 | 2015-07-01 | 肖文明 | Pure maca tablet granulated and tableted by use of dry method without accessories and preparation method of pure maca tablet |
-
2016
- 2016-08-11 CN CN201610655479.1A patent/CN106265827A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1803025A (en) * | 2006-01-13 | 2006-07-19 | 宁波大学 | Laver product and its making process |
| CN102406178A (en) * | 2011-10-12 | 2012-04-11 | 丽江程海保尔生物开发有限公司 | Spirulina tablet added with glycerol and processing method thereof |
| CN104095897A (en) * | 2014-06-24 | 2014-10-15 | 伏思思 | Maca dunaliella salina compound preparation |
| CN104738618A (en) * | 2015-02-15 | 2015-07-01 | 肖文明 | Pure maca tablet granulated and tableted by use of dry method without accessories and preparation method of pure maca tablet |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101194678B (en) | Health care feedstuff for sheep | |
| CN101574101A (en) | Natural holophytic-nutrition compressed biscuit and preparation method thereof | |
| CN103190567A (en) | Wheat germ alimentary noodles and manufacturing method thereof | |
| CN102224914A (en) | Purple sweet potato rice paste and preparation method thereof | |
| CN102428996A (en) | Arrowroot-series nutritional health care cake and biscuit food and preparation method thereof | |
| CN101194677A (en) | Health care feedstuff for rabbit | |
| CN102150555A (en) | Method for culturing pleurotus geesteranus uniformly rich in selenium by using mixed selenium source | |
| CN106615998A (en) | Carp fodder and application | |
| CN103583886B (en) | A kind of chicken feed preventing global-worm illness | |
| CN102388938A (en) | Macadamia nut flaky pastry and processing method thereof | |
| CN105166923A (en) | Health-care corn peptide food and making method | |
| CN101999713B (en) | Spirulina tablets and preparation method thereof | |
| CN102475173A (en) | Weight reducing tea and preparation method thereof | |
| CN102177809B (en) | Method for carrying out uniform selenium-enriched cultivation of pleurotus geesteranus by using selenium yeast | |
| CN102754765A (en) | Process for producing peony seed nutrition powder | |
| KR101526061B1 (en) | Granule comprising yam as a main component and its prodcution methods | |
| CN105767518A (en) | Feed capable of improving animal meat quality and flavor as well as preparation method thereof | |
| CN103315115B (en) | Organic tartary buckwheat-quinoa tea and its production method | |
| CN104187472A (en) | Donkey milk and seed melon nutrition powder | |
| CN106912717A (en) | A kind of black pig broad sow feed and preparation method | |
| CN103202429A (en) | Chicken bone beatifying vermicelli and preparation method thereof | |
| CN102273562A (en) | Preparation method of feed for facilitating piglets | |
| CN102302117B (en) | Momordica grosvenori vitamin C effervescent tablets and preparation process thereof | |
| CN106265827A (en) | A kind of processing method of Lepidinm meyenii Walp tablet | |
| CN101396056B (en) | Pine-needle tuckahoe teat and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170104 |
|
| RJ01 | Rejection of invention patent application after publication |